Market Cap 3.98B
Revenue (ttm) 9.09M
Net Income (ttm) -156.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 4.10
Profit Margin -1,720.90%
Debt to Equity Ratio 0.03
Volume 100
Avg Vol 1,016
Day's Range N/A - N/A
Shares Out 71.02M
Stochastic %K 10%
Beta 0.74
Analysts Strong Sell
Price Target $26.00

Company Profile

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insul...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 88 77 36 00
Fax: 45 88 77 38 98
Address:
Sydmarken 11, Søborg, Denmark
Latest News on ZLDPF
No data available.